Excitatory Cholinergic and Purinergic Signaling in Bladder Are Equally Susceptible to Botulinum Neurotoxin A Consistent with Co-Release of Transmitters from Efferent Fibers

被引:44
作者
Lawrence, Gary W. [1 ]
Aoki, K. Roger [2 ]
Dolly, J. Oliver [1 ]
机构
[1] Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland
[2] Allergan Pharmaceut Inc, Irvine, CA USA
基金
爱尔兰科学基金会;
关键词
RAT URINARY-BLADDER; TOXIN TYPE-A; SPINAL-CORD-INJURY; SENSORY NEURONS; SMOOTH-MUSCLE; P2X RECEPTORS; ATP RELEASE; PHYSIOLOGY; RESPONSES; DETRUSOR;
D O I
10.1124/jpet.110.169342
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mediators of neuromuscular transmission in rat bladder strips were dissected pharmacologically to examine their susceptibilities to inhibition by botulinum neurotoxins (BoNTs) and elucidate a basis for the clinical effectiveness of BoNT/A in alleviating smooth muscle spasms associated with overactive bladder. BoNT/A, BoNT/C1, or BoNT/E reduced peak and average force of muscle contractions induced by electric field stimulation (EFS) in dose-dependent manners by acting only on neurogenic, tetrodotoxin-sensitive responses. BoNTs that cleaved vesicle-associated membrane protein proved to be much less effective. Acetylcholine (ACh) and ATP were found to provide virtually all excitatory input, because EFS-evoked contractions were abolished by the muscarinic receptor antagonist, atropine, combined with either a desensitizing agonist of P2X(1) and P2X(3) or a nonselective ATP receptor antagonist. Both transmitters were released in the innervated muscle layer and, thus, persisted after removal of urothelium. Atropine or a desensitizer of the P2X(1) or P2X(3) receptors did not alter the rate at which muscle contractions were weakened by BoNT/A. Moreover, although cholinergic and purinergic signaling could be partially delineated by using high-frequency EFS (which intensified a transient, largely atropine-resistant spike in muscle contractions that was reduced after P2X receptor desensitization), they proved equally susceptible to BoNT/A. Thus, equi-potent blockade of ATP co-released with ACh from muscle efferents probably contributes to the effectiveness of BoNT/A in treating bladder overactivity, including nonresponders to anticholinergic drugs. Because purinergic receptors are known mediators of sensory afferent excitation, inhibition of efferent ATP release by BoNT/A could also help to ameliorate acute pain and urgency sensation reported by some recipients.
引用
收藏
页码:1080 / 1086
页数:7
相关论文
共 39 条
[1]   The Uroepithelial-associated sensory web [J].
Apodaca, G. ;
Balestreire, E. ;
Birder, L. A. .
KIDNEY INTERNATIONAL, 2007, 72 (09) :1057-1064
[2]   Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity [J].
Apostolidis, A ;
Dasgupta, P ;
Fowler, CJ .
EUROPEAN UROLOGY, 2006, 49 (04) :644-650
[3]   Urothelial signaling [J].
Birder, Lori A. .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2010, 153 (1-2) :33-40
[4]   SELECTIVE LOCATION OF ACCEPTORS FOR BOTULINUM NEUROTOXIN-A IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS [J].
BLACK, JD ;
DOLLY, JO .
NEUROSCIENCE, 1987, 23 (02) :767-779
[5]   BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25 [J].
BLASI, J ;
CHAPMAN, ER ;
LINK, E ;
BINZ, T ;
YAMASAKI, S ;
DECAMILLI, P ;
SUDHOF, TC ;
NIEMANN, H ;
JAHN, R .
NATURE, 1993, 365 (6442) :160-163
[6]   PURINERGIC INNERVATION OF GUINEA-PIG URINARY-BLADDER [J].
BURNSTOCK, G ;
COCKS, T ;
CROWE, R ;
KASAKOV, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1978, 63 (01) :125-138
[7]   Physiology and pathophysiology of purinergic neurotransmission [J].
Burnstock, Geoffrey .
PHYSIOLOGICAL REVIEWS, 2007, 87 (02) :659-797
[8]  
CHANCELLOR MB, 2009, BOTULINUM TOXIN THER, P231
[9]   Drug Insight: biological effects of botulinum toxin A in the lower urinary tract [J].
Chancellor, Michael B. ;
Fowler, Clare J. ;
Apostolidis, Apostolos ;
de Groat, William C. ;
Smith, Christopher P. ;
Somogyi, George T. ;
Aoki, K. Roger .
NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (06) :319-328
[10]   Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice [J].
Cockayne, DA ;
Hamilton, SG ;
Zhu, QM ;
Dunn, PM ;
Zhong, Y ;
Novakovic, S ;
Malmberg, AB ;
Cain, G ;
Berson, A ;
Kassotakis, L ;
Hedley, L ;
Lachnit, WG ;
Burnstock, G ;
McMahon, SB ;
Ford, APDW .
NATURE, 2000, 407 (6807) :1011-1015